Researchers Marwan Salih Mohamud Al-Nimer and Rozhgar Faisal Ahmed from the College of Ausool Al-Deen University in Baghdad, Iraq, investigated the efficacy of short-term diuretic treatment for resistant hypertension. In an open-label clinical study involving 120 patients, participants were treated with either a combination of amiloride and hydrochlorothiazide, spironolactone, or solely hydrochlorothiazide. All groups witnessed notable reductions in both systolic and diastolic blood pressure. Spironolactone was determined to be the most logical choice for treating resistant hypertension after a two-week regimen.
You may also like
Revolutionizing Cooling: Breakthrough in Thermoacoustic Refrigerator Efficiency
A team led by Prof. LUO Ercang from the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences has made a significant breakthrough in cooling technology by developing an innovative heat-driven...
186 views
Revolutionary Pain Relief: Ultrasound Technology Targets Brain for Non-Invasive Treatment
Recent advancements in medical research have brought forward a groundbreaking method of pain management that does not rely on traditional medication. This innovative approach, spearheaded by Wynn Legon, an assistant...
1,836 views
Gene-Editing Breakthrough: CRISPR Therapy Offers New Hope for Hereditary Angioedema Patients
A groundbreaking study involving a collaborative effort from researchers at the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals has marked a significant milestone in the...
1,744 views
Add comment